BioCryst Pharma Stock Price (NASDAQ:BCRX)

Add to My Stocks
$6.49 $0.01 (0.15%) BCRX stock closing price Apr 25, 2017 (Closing)
YOUR DAILY UPDATE ON
BCRX
BioCryst Pharma
25 APR 2017
amigobulls logo
BCRX hand_up
BCRX vs S&P 500
Closing Price: Apr 25, 2017
BCRX
$6.49 ( 0.15%)
S&P 500
2388.6 ( 0.61%)
BCRX
52 Week Price Range
1 Year Return: 78.51%
Q4 Growth*
Excellent
Profitable ?
No
net image
2016 Q4 Net Loss
-209.3%
home image
Rating
BCRX POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

BioCryst Pharma Snapshot Video

12 5 2

BCRX Stock Details

Prev Close* : $6.48
Market Cap:
$520.85M
Day Low: $6.46
52 Week Low: $2.49
Open: $6.54
Volume: 522393
Day High: $6.68
52 Week High: $9.25
Dividend:
N/A

Latest Stock Market News

Latest Articles

BioCryst Pharma News - From Partners

BCRX Stockcharts

View BCRX PE ratio, PS ratio stocks charts and compare with peers.
BCRX Chart
Note: Compare BioCryst Pharma stock price history with the index and industry peers.

BioCryst Pharma Valuation

PS ratio (
price to sales ratio
)
18.17
PB ratio (
price to book ratio
)
25.34

BioCryst Pharma Financial Ratios

Asset Turnover
0.4
Receivables Turnover
4.31
Debt to Equity
34.21

BCRX Industry Peers

Company Price Change (%)
Enanta Pharma (ENTA)31.310.28 (0.9%)
Ardelyx (ARDX)13.180.63 (5.02%)
Gilead Sciences (GILD)67.120.87 (1.31%)
Sarepta Therapeutics (SRPT)35.811.79 (5.26%)
Aviragen Therapeutics (AVIR)0.620.02 (3.33%)
Achillion Pharma (ACHN)3.480.27 (8.41%)
Nanoviricides (NNVC)1.150.04 (3.6%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
CTI BioPharma (CTIC)4.260.28 (7.04%)
USANA Health Sciences (USNA)58.553.3 (5.97%)
Ignyta (RXDX)8.950.5 (5.92%)
ImmunoGen (IMGN)4.330.22 (5.35%)
Valeant Pharmaceuticals Intl Inc (VRX)9.020.42 (4.88%)
Ionis Pharma (IONS)47.882.14 (4.68%)
Spectrum Pharma (SPPI)7.630.32 (4.38%)
Top gainers from Medical-Drugs industry
* As of Apr 26, 2017
CompanyPriceChange (%)
Karyopharm Therapeutics (KPTI)10.410.9 (7.96%)
Durect (DRRX)0.8430.05 (5.61%)
Genocea Biosciences (GNCA)6.860.24 (3.38%)
Nature's Sunshine Products (NATR)9.90.3 (2.94%)
Egalet (EGLT)4.230.11 (2.53%)
AcelRx Pharma (ACRX)2.550.05 (1.92%)
Esperion Therapeutics (ESPR)37.050.49 (1.31%)
Top losers from Medical-Drugs industry
* As of Apr 26, 2017

BioCryst Pharmaceuticals, Inc. Stock News - Partner Headlines

BioCryst Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues26.35M48.25M13.6M17.33M26.29M
Net Income-55.14M-43.01M-45.18M-30.1M-39.08M
Total Operating Expense72.65M86.32M59.37M48.04M60.17M
view BioCryst Pharmaceuticals, Inc. income statement
balance sheet20162015201420132012
Total Assets89.84M124.55M136.87M48.86M57.43M
Total Liabilities88.26M76.83M61.23M49.99M57.89M
Shareholders Equity1.57M47.72M75.63M-1.12M-0.45M
view BioCryst Pharmaceuticals, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-7.55M19.01M1.3M3.8M-4.29M
Net Cash From (Used By) Operating Activities-53.43M-13.11M-38.55M-26.53M-37.39M
Increase (Decrease) In Prop Plant And Equipment-5.27M-5.12M-0.1M0.02M-0.11M
view BioCryst Pharmaceuticals, Inc. cashflow statement

BioCryst Pharma Stock Message Board

BioCryst Pharma stock lost 0.15 %, and the last close price as of 25 Apr, 2017 is 6.49 for BCRX stock. BioCryst Pharma market capitalization is 520.85M and it represents the total market value of BCRX stock. A value investor must look at the fundamentals of a stock, and perform BioCryst Pharma valuation, even though in the short-term sentiment and current breaking news might affect BioCryst Pharma stock price.

For recognizing and analyzing the real performance of BioCryst Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 522393 shares were traded with a closing stock price of 6.49 as of 25 Apr, 2017, as can be seen from BioCryst Pharma stock quote. One can view BioCryst Pharma stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. BioCryst Pharma does not pay dividends. BioCryst Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.